Leadership Overview
Syngene has 4 executives leading key functions including corporate strategy, operational excellence, financial management, and digital infrastructure.
Focused on advancing global scientific research, Syngene delivers comprehensive discovery and development services to pharmaceutical and biotechnology partners while maintaining rigorous standards in medicinal chemistry, toxicology, and cGMP manufacturing across international markets.
Focused on advancing global scientific research, Syngene delivers comprehensive discovery and development services to pharmaceutical and biotechnology partners while maintaining rigorous standards in medicinal chemistry, toxicology, and cGMP manufacturing across international markets.
Leadership Roles at Syngene
Siddharth Mittal - Chief Executive Officer & Managing Director
Siddharth Mittal, the Chief Executive Officer & Managing Director at Syngene, directs the overarching corporate strategy and long-term growth trajectory for the organization. By overseeing the integration of medicinal chemistry and cGMP manufacturing services, the Chief Executive Officer & Managing Director ensures alignment with the evolving needs of global pharmaceutical partners. This leadership role involves constant engagement with the Board to refine operational priorities and expand market reach across diverse international territories. Siddharth Mittal drives the company mission by fostering innovation in discovery and development services, ensuring that scientific excellence remains the primary competitive advantage. Through the optimization of internal processes and the pursuit of strategic partnerships, the Chief Executive Officer & Managing Director secures the financial health and technical reputation of the firm. Ultimately, Mittal maintains a focus on delivering high-value research solutions that accelerate the drug development lifecycle for clients worldwide.
Ankush Balani - Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office)
Ankush Balani, the Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) at Syngene, directs the fiscal health and capital allocation strategies of the organization. Overseeing the financial planning and investor relations functions, the Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) ensures transparency and growth in shareholder value. This role involves evaluating potential mergers and acquisitions to expand the service portfolio in medicinal chemistry and biology. Ankush Balani drives the financial stability of the company by managing corporate finance initiatives and aligning business finance with long-term strategic objectives. By analyzing market trends and economic indicators, the Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) provides the necessary data to support executive decision-making. Balani secures the resources required for continued investment in R&D infrastructure, ensuring that the firm maintains a strong competitive position within the global contract research market.
Arvind Atignal - Chief Operating Officer
Arvind Atignal, the Chief Operating Officer at Syngene, manages the daily execution of complex research and manufacturing workflows. Overseeing the laboratory operations and process R&D departments, the Chief Operating Officer ensures that all custom synthesis and formulation projects meet stringent quality benchmarks. This role requires constant coordination with technical teams to maintain efficiency in the delivery of discovery services. Arvind Atignal drives operational excellence by streamlining resource allocation and optimizing the utilization of high-end scientific infrastructure. By monitoring project timelines and output quality, the Chief Operating Officer supports the broader organizational goal of providing reliable contract research services to global clients. Atignal maintains a focus on scaling production capabilities to meet increasing demand in the pharmaceutical sector. Through the implementation of robust operational frameworks, the Chief Operating Officer guarantees that the company remains a preferred partner for complex development projects, consistently delivering results that satisfy rigorous industry standards.
Ajit Manocha - Syngene Vice President & Chief Information Officer (Biocon Group)
Ajit Manocha, the Syngene Vice President & Chief Information Officer (Biocon Group) at Syngene, directs the digital transformation and information technology strategy for the entire organization. Overseeing the implementation of secure data management systems and advanced analytics, the Syngene Vice President & Chief Information Officer (Biocon Group) ensures that research data remains protected and accessible for scientific teams. This role involves integrating complex IT infrastructure with laboratory information management systems to enhance productivity in discovery and development services. Ajit Manocha drives the technological evolution of the company by deploying scalable cloud solutions and cybersecurity protocols that support global operations. By aligning digital capabilities with the needs of the R&D departments, the Syngene Vice President & Chief Information Officer (Biocon Group) facilitates seamless collaboration across international research sites. Manocha maintains a focus on leveraging technology to improve operational efficiency, ensuring that the firm utilizes cutting-edge digital tools to maintain a leadership position in the contract research and manufacturing industry.
Explore Leadership Teams in Business Services
Genentech, based in South San Francisco, California, is a biotechnology company specializing in the development of innovative therapies for serious medical conditions. Founded in 1976, Genentech serves the healthcare sector with a focus on research and development of biopharmaceuticals to improve patient outcomes.
Company Leadership AM
RC
LL
NSF International is an independent, founded in 1944 is a not-for-profit organization that provides standards development, product certification, auditing, education, and risk management for public health and the environment. NSF serves industries from aerospace to pharma and biotech. NSF International is headquartered out of Ann Arbor, Michigan.
Company Leadership
KB
GB
AD
The National Laboratory of the Rockies, located in Golden, Colorado, is a national laboratory of the United States Department of Energy specializing in energy systems research and development. Formerly known as the National Renewable Energy Laboratory until December 2025, NLR serves as the primary federal laboratory for advancing energy technologies across the entire energy spectrum, from generation to distribution to end use. The laboratory conducts multidisciplinary research in renewable energy, energy efficiency, energy systems integration, sustainable transportation, bioenergy, photovoltaics, wind energy, hydrogen and fuel cells, energy storage, and advanced materials science. NLR operates state-of-the-art research facilities including the Energy Systems Integration Facility, Solar Energy Research Facility, and maintains high-performance computing capabilities. The laboratory partners with industry, government agencies, academia, and other national laboratories to bridge foundational research with practical applications. NLR develops data sets, analytical tools, and models for energy technology analysis while working to lower energy costs, drive economic growth, strengthen national security, and ensure abundant energy for the nation. The laboratory maintains campuses in Golden and Arvada, Colorado, as well as Fairbanks, Alaska, and is operated under contract for the Department of Energy's Office of Critical Minerals and Energy Innovation by the Alliance for Sustainable Energy.
Company Leadership TH
GH
JL
NCI is attempting to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers.
Company Leadership
GT
JH
JR
Frequently Asked Questions Regarding Syngene Top Executives and Leadership Team
